Related Experiment Video
Updated: Nov 18, 2025

08:58
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
253
Recent progress on surfactant protein A: cellular function in lung and kidney disease development
Skylar D King1, Shi-You Chen1,2
1Department of Surgery, University of Missouri School of Medicine, Columbia, Missouri.
American Journal of Physiology. Cell Physiology
|July 9, 2020
Summary
Surfactant protein A (SP-A) is crucial for lung function by reducing surface tension and modulating immune responses. SP-A dysfunction is linked to lung and kidney diseases, making it a potential biomarker for disease outcomes.
Area of Science:
- Pulmonary medicine
- Cell biology
- Immunology
Background:
- Pulmonary surfactant, a complex of lipids and proteins, is essential for respiratory mechanics.
- Surfactant protein A (SP-A) is a key glycoprotein component of pulmonary surfactant.
- SP-A plays vital roles in reducing alveolar surface tension and immune defense.
Purpose of the Study:
- To review the functions of SP-A.
- To discuss SP-A's role in lung and kidney pathologies.
- To explore SP-A as a biomarker for lung disease outcomes.
Main Methods:
- Literature review of studies on SP-A function and pathology.
- Analysis of human and animal models investigating SP-A deficiencies.
- Examination of SP-A's utility as a diagnostic biomarker.
Main Results:
- SP-A is critical for preventing alveolar collapse and regulating immune responses.
- SP-A deficiencies or mutations are associated with lung and kidney diseases.
- SP-A shows potential as a biomarker for predicting lung disease progression.
Conclusions:
- SP-A is a multifunctional protein vital for lung health and immune homeostasis.
- Dysfunctional SP-A contributes to the pathogenesis of specific lung and kidney disorders.
- SP-A holds promise as a valuable biomarker in respiratory medicine.
Related Concept Videos
Breathing
62.4K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
62.4K
Aquaporins
5.7K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
5.7K
Cystic Fibrosis: Pathogenesis
548
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
548

